COLUMN GROUP III GP, LP

Insider Reports History

Location
San Francisco, CA
Signature
/s/ The Column Group III GP, LP /s/ James Evangelista, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by COLUMN GROUP III GP, LP:

Company Role Class Num Shares Value Price $ Report Date Ownership
Tenaya Therapeutics, Inc. 10%+ Owner Common Stock 49,313,559 $34,519,491 $0.7000 05 Mar 2025 Indirect
Surrozen, Inc./DE 10%+ Owner Common Stock 999,429 $19,976,886 $19.99 14 Jan 2026 By The Column Group III-A, LP
Surrozen, Inc./DE 10%+ Owner Common Stock 885,014 $17,689,925 $19.99 14 Jan 2026 By The Column Group III, LP
Surrozen, Inc./DE 10%+ Owner Common Stock 344,827 $8,258,606 $23.95 13 Jan 2026 By The Column Group Opportunity III, LP
Tenaya Therapeutics, Inc. 10%+ Owner Series A Warrant (right to buy) 35,714,284 05 Mar 2025 Indirect
Tenaya Therapeutics, Inc. 10%+ Owner Series B Warrant (right to buy) 17,857,142 05 Mar 2025 Indirect
Surrozen, Inc./DE 10%+ Owner Second Tranche Units (Right to Buy) 548,653 26 Mar 2025 By The Column Group III-A, LP
Surrozen, Inc./DE 10%+ Owner Second Tranche Units (Right to Buy) 517,241 26 Mar 2025 By The Column Group Opportunity II, LP
Surrozen, Inc./DE 10%+ Owner Second Tranche Units (Right to Buy) 485,830 26 Mar 2025 By The Column Group III, LP
Surrozen, Inc./DE 10%+ Owner Series E Common Warrants 182,884 26 Mar 2025 By The Column Group III-A, LP
Surrozen, Inc./DE 10%+ Owner Series E Common Warrants 172,414 26 Mar 2025 By The Column Group Opportunity II, LP
Surrozen, Inc./DE 10%+ Owner Series E Common Warrants 161,943 26 Mar 2025 By The Column Group III, LP
Surrozen, Inc./DE 10%+ Owner Series B Common Warrants 111,656 26 Mar 2025 By The Column Group III-A, LP
Surrozen, Inc./DE 10%+ Owner Series A Common Warrants 102,651 26 Mar 2025 By The Column Group III-A, LP
Surrozen, Inc./DE 10%+ Owner Series B Common Warrants 98,870 26 Mar 2025 By The Column Group III, LP
Surrozen, Inc./DE 10%+ Owner Series A Common Warrants 90,897 26 Mar 2025 By The Column Group III, LP
Surrozen, Inc./DE 10%+ Owner Series C Common Warrants 0 26 Mar 2025 By The Column Group III-A, LP
Surrozen, Inc./DE 10%+ Owner Series C Common Warrants 0 26 Mar 2025 By The Column Group III, LP
Surrozen, Inc./DE 10%+ Owner Series D Common Warrants 0 26 Mar 2025 By The Column Group III-A, LP
Surrozen, Inc./DE 10%+ Owner Series D Common Warrants 0 26 Mar 2025 By The Column Group III, LP

Insider Reports Filed by COLUMN GROUP III GP, LP

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SRZN Surrozen, Inc./DE 13 Jan 2026 4 +$357,353 4 10%+ Owner 15 Jan 2026, 16:10
SRZN Surrozen, Inc./DE 06 Jan 2026 2 +$300,297 4 10%+ Owner 08 Jan 2026, 17:23
SRZN Surrozen, Inc./DE 04 Dec 2025 4 +$694,850 4 10%+ Owner 08 Dec 2025, 17:04
SRZN Surrozen, Inc./DE 13 Nov 2025 2 +$3,990,531 4 10%+ Owner 17 Nov 2025, 19:15
SRZN Surrozen, Inc./DE 26 Mar 2025 21 +$11,999,991 4 10%+ Owner 28 Mar 2025, 20:57
TNYA Tenaya Therapeutics, Inc. 05 Mar 2025 3 +$24,999,999 4 10%+ Owner 07 Mar 2025, 19:14
SRZN Surrozen, Inc./DE 04 Apr 2024 2 +$2,999,994 4/A 10%+ Owner 17 Apr 2024, 16:14
SRZN Surrozen, Inc./DE 04 Apr 2024 10 +$2,999,994 4 10%+ Owner 08 Apr 2024, 16:23
TNYA Tenaya Therapeutics, Inc. 12 Feb 2024 1 +$9,999,999 4 10%+ Owner 14 Feb 2024, 16:15
TNYA Tenaya Therapeutics, Inc. 10 Mar 2023 1 +$17,596 4 10%+ Owner 14 Mar 2023, 16:12
TNYA Tenaya Therapeutics, Inc. 08 Feb 2023 1 +$3,900,000 4 10%+ Owner 10 Feb 2023, 15:32
TNYA Tenaya Therapeutics, Inc. 19 Jan 2023 1 +$174,201 4 10%+ Owner 23 Jan 2023, 15:25
TNYA Tenaya Therapeutics, Inc. 17 Jan 2023 2 +$464,827 4 10%+ Owner 19 Jan 2023, 15:18
TNYA Tenaya Therapeutics, Inc. 21 Nov 2022 1 +$24,999,998 4 10%+ Owner 23 Nov 2022, 15:12
SRZN Surrozen, Inc./DE 11 Aug 2021 0 $0 3 10%+ Owner 16 Aug 2021, 20:16
TNYA Tenaya Therapeutics, Inc. 03 Aug 2021 8 $0 4 10%+ Owner 04 Aug 2021, 18:34
TNYA Tenaya Therapeutics, Inc. 29 Jul 2021 0 $0 3 10%+ Owner 29 Jul 2021, 20:28